The results of this study suggest that endotoxin and FABP2/I-FABP may be used for indicating intestinal damage, creatinine for kidney damage, and AST and FABP1/L-FABP for liver damage during the post-REBOA phase. This evidence concerns the gene FABP2 and Nephropathy.